Biosynex Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
292
- Stock Symbol
-
ALBIO
- Investments
-
23
- Share Price
-
$5.03
- (As of Friday Closing)
Biosynex General Information
Description
Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.
Contact Information
Website
www.biosynex.comCorporate Office
- 22 Boulevard Sébastien Brant
- Graffenstaden
- 67400 Illkirch
- France
Corporate Office
- 22 Boulevard Sébastien Brant
- Graffenstaden
- 67400 Illkirch
- France
Biosynex Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.03 | $5.00 | $3.03 - $9.83 | $54.2M | 10.8M | 17.2K | -$3.73 |
Biosynex Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2023 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 132,491 | 132,491 | 104,647 | 292,172 |
| Revenue | 100,609 | 100,609 | 206,692 | 452,268 |
| EBITDA | (13,021) | (13,021) | 42,126 | 173,233 |
| Net Income | (39,978) | (39,978) | 16,462 | 122,964 |
| Total Assets | 267,207 | 267,207 | 279,189 | 304,505 |
| Total Debt | 72,512 | 72,512 | 55,847 | 39,813 |
Biosynex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biosynex Comparisons
Industry
Financing
Details
Biosynex Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lumos Diagnostics | Formerly VC-backed | South Melbourne, Australia | ||||
| HemoCue | Corporate Backed or Acquired | Ängelholm, Sweden | ||||
| Twistdx | Corporate Backed or Acquired | Maidenhead, United Kingdom | ||||
| ProciseDx | Formerly VC-backed | San Diego, CA | ||||
| QuantuMDx | Venture Capital-Backed | Newcastle Upon Tyne, United Kingdom |
Biosynex Patents
Biosynex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-212808-S | Thermometer [including medical thermometer] with its charging holder | Active | 25-Oct-2021 | ||
| CA-212807-S | Medical thermometer | Active | 25-Oct-2021 | ||
| CA-212809-S | Charging holder for medical thermometer | Active | 25-Oct-2021 | ||
| FR-3079716-B1 | Insect repellent composition comprising insectic fatty acid having between 9 and 21 carbon atoms | Active | 05-Apr-2018 | ||
| FR-3079716-A1 | Insective composition comprising an insective fatty acid having between 9 and 21 carbon atoms | Active | 05-Apr-2018 | A01N37/02 |
Biosynex Executive Team (3)
| Name | Title | Board Seat |
|---|---|---|
| Larry Abensur | Co-Founder & Chief Executive Officer | |
| Thierry Paper | Co-Founder & Deputy Managing Director | |
| Thomas Lamy Ph.D | Co-Founder & Vice President |
Biosynex Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Self | Board Member | ||
| Biosynex | Co-Founder & Chief Executive Officer | ||
| Biosynex | Co-Founder & Deputy Managing Director |
Biosynex Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biosynex Investments & Acquisitions (23)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ProciseDx | 09-Jun-2023 | Diagnostic Equipment | |||
| Innoxa Laboratories (Eye Care Activity) | 08-Jun-2023 | Clinics/Outpatient Services | |||
| Chembio Diagnostic | 27-Apr-2023 | Diagnostic Equipment | |||
| Biosynex Iberica | 23-Mar-2023 | Laboratory Services (Healthcare) | |||
| TheraDiag | 31-Jan-2023 | Merger/Acquisition | Diagnostic Equipment |
Biosynex Subsidiaries (12)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Doc2U | Diagnostic Equipment | Toulouse, France | 2020 |
| ProciseDx | Diagnostic Equipment | San Diego, CA | |
| Medkoncept | Laboratory Services (Healthcare) | Hellerup, Denmark | |
| Enalees | Other Consumer Durables | Evry, France | |
| Avalun | Diagnostic Equipment | Grenoble, France |
Biosynex ESG
Risk Overview
Risk Rating
Updated August, 08, 2023
33.91 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Healthcare
Industry
of 634
Rank
Percentile
Medical Devices
Subindustry
of 225
Rank
Percentile
Biosynex FAQs
-
When was Biosynex founded?
Biosynex was founded in 2005.
-
Who is the founder of Biosynex?
Larry Abensur, Thierry Paper, and Thomas Lamy Ph.D are the founders of Biosynex.
-
Who is the CEO of Biosynex?
Larry Abensur is the CEO of Biosynex.
-
Where is Biosynex headquartered?
Biosynex is headquartered in Illkirch, France.
-
What is the size of Biosynex?
Biosynex has 292 total employees.
-
What industry is Biosynex in?
Biosynex’s primary industry is Diagnostic Equipment.
-
Is Biosynex a private or public company?
Biosynex is a Public company.
-
What is Biosynex’s stock symbol?
The ticker symbol for Biosynex is ALBIO.
-
What is the current stock price of Biosynex?
As of 11-Oct-2024 the stock price of Biosynex is $5.03.
-
What is the current market cap of Biosynex?
The current market capitalization of Biosynex is $54.2M.
-
What is Biosynex’s current revenue?
The trailing twelve month revenue for Biosynex is $101M.
-
Who are Biosynex’s competitors?
Lumos Diagnostics, HemoCue, Twistdx, ProciseDx, and QuantuMDx are some of the 9 competitors of Biosynex.
-
What is Biosynex’s annual earnings per share (EPS)?
Biosynex’s EPS for 12 months was -$3.73.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
